$179 Million is the total value of ACUTA CAPITAL PARTNERS, LLC's 43 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NUVB | Exit | NUVATION WARRANTS*w exp 07/07/202 | $0 | – | -90,832 | -100.0% | -0.03% | – |
| SEEL | Exit | SEELOS THERAPEUTICS INC | $0 | – | -295,896 | -100.0% | -0.12% | – |
| IMGN | Exit | IMMUNOGEN INC | $0 | – | -55,000 | -100.0% | -0.12% | – |
| ACIU | Exit | CALL- ACIU 100@7 1/2EXP 08/19/2022call | $0 | – | -100,000 | -100.0% | -0.19% | – |
| Exit | DICE THERAPEUTICS INC | $0 | – | -37,500 | -100.0% | -0.34% | – | |
| MTEM | Exit | MOLECULAR TEMPLATES INC | $0 | – | -307,125 | -100.0% | -0.50% | – |
| ATHA | Exit | CALL- ATHA 100@12 1/2 EXP 07/15/2022call | $0 | – | -100,000 | -100.0% | -0.63% | – |
| ATHA | Exit | ATHIRA PHARMA INC | $0 | – | -140,030 | -100.0% | -0.88% | – |
| PMVP | Exit | CALL- PMVP 100 @ 20 EXP 06/17/2022call | $0 | – | -100,000 | -100.0% | -0.97% | – |
| HARP | Exit | HARPOON THERAPEUTICS INC | $0 | – | -497,500 | -100.0% | -1.16% | – |
| AVDL | Exit | AVADEL PHARMACEUTICALS PLCsponsored adr | $0 | – | -580,000 | -100.0% | -1.85% | – |
| JNCE | Exit | JOUNCE THERAPEUTICS INC | $0 | – | -813,500 | -100.0% | -2.58% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS INC | 24 | Q1 2023 | 21.2% |
| IRIDEX CORP | 20 | Q3 2019 | 8.1% |
| ARROWHEAD PHARMACEUTICALS INC | 20 | Q2 2023 | 7.9% |
| IMMUNOMEDICS INC | 19 | Q3 2020 | 20.6% |
| VERACYTE INC | 19 | Q3 2019 | 10.1% |
| ASCENDIS PHARMA A S | 18 | Q2 2020 | 7.2% |
| XENON PHARMACEUTICALS INC | 18 | Q3 2022 | 4.6% |
| CAS MED SYS PAR $0.004 | 18 | Q1 2019 | 6.4% |
| APELLIS PHARMACEUTICALS INC | 17 | Q3 2023 | 18.4% |
| KURA ONCOLOGY INC. COMMON STOCK | 17 | Q3 2023 | 8.1% |
View ACUTA CAPITAL PARTNERS, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| BCLS Acquisition Corp.Sold out | February 14, 2023 | 0 | 0.0% |
| Jiya Acquisition Corp.Sold out | February 14, 2023 | 0 | 0.0% |
| VistaGen Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Larimar Therapeutics, Inc.Sold out | February 15, 2022 | 0 | 0.0% |
| CATALYST BIOSCIENCES, INC.Sold out | February 14, 2022 | 0 | 0.0% |
| Aadi Bioscience, Inc. | September 07, 2021 | 1,529,402 | 7.2% |
| Kadmon Holdings, Inc. | February 14, 2020 | 7,373,333 | 4.6% |
| IRIDEX CORPSold out | November 13, 2019 | 0 | 0.0% |
| ASSEMBLY BIOSCIENCES, INC. | February 14, 2019 | 718,500 | 2.8% |
| CAS MEDICAL SYSTEMS INC | February 14, 2019 | 5,263,508 | 18.2% |
View ACUTA CAPITAL PARTNERS, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
View ACUTA CAPITAL PARTNERS, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.